Compound guides.Built for researchers.

A dual GIP/GLP-1 receptor agonist with a unique incretin pharmacology. We examine its receptor targets, signalling axes, and role in metabolic pathway research.

The first triple receptor agonist to target GLP-1, GIP, and glucagon simultaneously. We explore what this means for receptor pharmacology research.

An overview of the glucagon-like peptide-1 receptor, incretin biology, and how GLP-1 agonists are classified and studied in laboratory settings.

BPC-157 is a synthetic pentadecapeptide studied across tissue biology models. We explore its research profile and its role in the KLOW multi-peptide compound.

Three compounds at the frontier of mitochondrial and longevity research. We examine their distinct mechanisms and what each brings to cellular biology studies.

Same compound, different format — we compare vials and pre-filled pens on real cost-per-mg pricing, purity verification, and dosing flexibility.

UK domestic stock, dispatch times, and pricing across 10mg, 20mg, 40mg and 60mg — everything to check before ordering Tirzepatide.

What to look for when sourcing Retatrutide from a UK supplier — stock, dispatch, and pricing across 10mg, 30mg, 40mg and 60mg.

A guide to sourcing Semaglutide for research from a UK-based supplier, covering stock, dispatch, and pricing.

What the pre-blended BPC-157/TB-500 vial format means for dosing flexibility, plus UK stock and dispatch details.

A guide to sourcing GHK-Cu for research — lyophilised vial format, UK stock, and dispatch.

What to check before ordering NAD+ for research — vial format, UK stock, and dispatch from a domestic supplier.

A wider overview of buying research peptides in the UK — what "UK domestic stock" actually means, and what separates a reliable supplier from the rest.

What actually separates one UK peptide supplier from another — stock, dispatch, purity, and the questions worth asking before you order.